2010, Controlled Substances and Hospitals

Search:

DAY

WEEK

MONTH

YEAR

MORE

Select your country:
Sign up | Log in

2010

Controlled Substances

Hospitals

Surely You Must be Kidding, PTO?!? “No, and Don’t Call Me Shirley!” – The Seemingly Slapstick (But Yet Unfunny) World of Recent Patent Term Extension Decisions (PART 1)

FDA Law Blog: Biosimilars

FEBRUARY 27, 2024

2010) , however, the U.S. The second multiple PTE case brewing concerns FoldRx’s (a wholly owned subsidiary of Pfizer, Inc.) Two PTE applications were submitted to FDA ( See FDA Docket Nos. FDA-2022-E-3123 and FDA-2022-E-3120) with respect to U.S. Patent Nos. 7,214,695 and 7,214,696. In PhotoCure v. Kappos, 603 F.3d 3d 1372 (Fed.

Controlled Substances

Controlled Substances Hospitals

Pharmacist Digest

Surely You Must be Kidding, PTO?!? “No, and Don’t Call Me Shirley!” – The Seemingly Slapstick (But Yet Unfunny) World of Recent Patent Term Extension Decisions (PART 1)

Stay Connected